abstract |
The present invention relates to substituted fused pyrimidine compounds of formula (I), tautomers, polymorphs, stereoisomers, prodrugs, solvates, pharmaceutically acceptable salts, pharmaceutical compositions containing them, And methods of treating conditions and diseases mediated by adenosine receptor (AR) activity. The present invention also provides a process for the preparation of compounds of formula (I). |